Spin-out companies
Our researchers are on an unrestricted search to develop a sustainable future, address global healthcare challenges, and alleviate social inequalities. Our spin-out portfolio reflects the excellence and diversity of this research mission.
Spin-outs creating a sustainable future
Using advanced algorithms to design better batteries and quicken the pace of battery development
An integrated technology solution that captures intelligent data in real-time, reducing daily energy consumption for rail operators
Accelerating the world’s transition to safer chemicals without vertebrate animal testing
Industrial and municipal waste water treatment that recovers more water for less energy
Spin-outs tackling global health challenges
A clinical-stage company developing gene therapies so the immune system recognises, attacks and clears tumours
A clinical-stage company developing novel therapeutics for eye surface diseases and injuries
Developing rapid point-of-care testing that detects multiple infectious diseases from a single sample
Experts in antibody engineering, revolutionising immunotherapy for precision tumour targeting and controlled immune activation
Advancing less invasive healthcare with an innovative multi-omics platform and cutting-edge machine learning systems
Spin-outs with new approaches to manufacturing, engineering, and healthcare
Reshaping the future of regenerative medicine with new resorbable biomaterials and implantable medical devices that help people heal
Redefining insulation with advanced electrospun fibres
Experts in amino acid analysis, peptide synthesis and protein sequencing for researchers and industry
A leader in large Stoke shift fluorescent probes for imaging applications and next generation fluorescent compounds
Developing a portable Quantum Technology to accurately detect buried features using gravity gradiometry
AI that helps teachers provide more feedback, more quickly, on maths, short text and essays
Developing novel materials that address the need for ever-decreasing microchip feature sizes in the semiconductor industry
Microbial specialists providing rapid, comprehensive, microbial gene and metagenomic sequencing
Premium quality antigens and antibodies for the diagnostic and biopharmaceutical industries
Our spin-outs in the news
Our spin-out process
The University Â鶹¾«Ñ¡ (UoBE) spin-out offering was reviewed in 2022. The offering has also been considered and updated in light of the findings of the government's and , both published in 2023.
Find out more
Contact us
We welcome approaches from potential investors as well as experienced individuals looking for executive and non-executive positions.
Email us to find out more